논문 목록
Issue Date Title Journals
2024-03 Feasibility of Intraoperative Radiotherapy Tumor Bed Boost in Patients with Breast Cancer after Neoadjuvant Chemotherapy Yonsei Medical Journal
2024-03 Tumor-Infiltrating Lymphocyte Level Consistently Correlates with Lower Stiffness Measured by Shear-Wave Elastography: Subtype-Specific Analysis of Its Implication in Breast Cancerr Cancers
2024-01 Elasticity Values as a Predictive Modality for Response to Neoadjuvant Chemotherapy in Breast Cancer Cancers
2023-11 Survival Outcomes in Premenopausal Patients With Invasive Lobular Carcinoma JAMA network open
2023-11 Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor-Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial Journal of clinical oncology : official journal of the American Society of Clinical Oncology
2023-10 YAP1 Expression in HR+HER2−Breast Cancer: 21-Gene Recurrence Score Analysis and Public Dataset Validation Cancers
2023-10 Efficacy of Limited Dose Modifications for Palbociclib-Related Grade 3 Neutropenia in Hormone Receptor-Positive Metastatic Breast Cancer Cancer Research and Treatment
2023-09 Copy number aberrations in circulating tumor DNA enables prognosis prediction and molecular characterization of breast cancer Journal of the National Cancer Institute
2023-09 Prognostic impact of radiotherapy-induced-lymphopenia in patients treated with breast-conservative surgery Scientific Reports
2023-08 Ki-67, 21-Gene Recurrence Score, Endocrine Resistance, and Survival in Patients With Breast Cancer Jama Network Open
2023-08 Investigation of Factors Affecting Adherence to Adjuvant Hormone Therapy in Early-Stage Breast Cancer Patients: A Comprehensive Systematic Review Journal of Breast Cancer
2023-08 Comparison of Programmed Cell Death Ligand 1 Status between Core Needle Biopsy and Surgical Specimens of Triple-Negative Breast Cancer Yonsei Medical Journal
2023-07 Predictive biological factors for late survival in patients with HER2-positive breast cancer Scientific Reports
2023-05 Optimal treatment strategy for hormone receptor-positive human epidermal growth factor receptor 2-negative breast cancer patients with 1-2 suspicious axillary lymph node metastases on breast magnetic resonance imaging: upfront surgery vs. neoadjuvant chemotherapy FRONTIERS IN ONCOLOGY
2023-05 Radiation dose-event relationship after intraoperative radiotherapy as a boost in patients with breast cancer FRONTIERS IN ONCOLOGY
2023-04 Resolution of Nonmass Enhancement Extension to the Nipple at Breast MRI after Neoadjuvant Chemotherapy: Pathologic Response and Feasibility for Nipple-sparing Mastectomy Radiology
2023-03 Reprogramming anchorage dependency by adherent-to-suspension transition promotes metastatic dissemination Molecular Cancer
2023-02 Complications Including Capsular Contracture in Direct-to-Implant Breast Reconstruction With Textured Anatomical Versus Smooth Round Implants: A Single Center Retrospective Analysis Journal of Breast Cancer
2023-01 On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates Breast Cancer Research
2023-01 Shear-wave elastography-based nomograms predicting 21-gene recurrence score for adjuvant chemotherapy decisions in patients with breast cancer EUROPEAN JOURNAL OF RADIOLOGY
2023-01 Anaemia and pathologic complete response rate according to carboplatin dose in HER2+breast cancer treated with neoadjuvant TCHP CANCER MEDICINE
2022-12 18F-FDG uptake of visceral adipose tissue on preoperative PET/CT as a predictive marker for breast cancer recurrence Scientific Reports
2022-12 Prognostic Value of Neutrophil- to-Lymphocyte Ratio and Early Standardized Uptake Value Reduction in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy JOURNAL OF BREAST CANCER
2022-11 Association of Body Mass Index With 21-Gene Recurrence Score Among Women With Estrogen Receptor-Positive, ERBB2-Negative Breast Cancer JAMA network open
2022-10 Residual Tumor Patterns of Breast Cancer on MRI after Neo-Adjuvant Chemotherapy: Impact on Clinicopathologic Factors and Prognosis Diagnostics
2022-10 Correlation of Yes-Associated Protein 1 with Stroma Type and Tumor Stiffness in Hormone-Receptor Positive Breast Cancer CANCERS
2022-08 Blood Test for Breast Cancer Screening through the Detection of Tumor-Associated Circulating Transcripts International Journal of Molecular Sciences
2022-08 CD39+ tissue-resident memory CD8+ T cells with a clonal overlap across compartments mediate antitumor immunity in breast cancer Science immunology
2022-07 The Risk Factors, Incidence and Prognosis of Postpartum Breast Cancer: A Nationwide Study by the SMARTSHIP Group FRONTIERS IN ONCOLOGY
2022-07 Effects of single nucleotide polymorphisms and Mediterranean diet in overweight or obese postmenopausal women with breast cancer receiving adjuvant hormone therapy: A pilot randomized controlled trial Frontiers in Nutrition
2022-07 SP142 PD-L1 Assays in Multiple Samples from the Same Patients with Early or Advanced Triple-Negative Breast Cancer CANCERS
2022-06 Low incidence of lymph node metastasis in patients with microinvasive breast cancer: a Korean nationwide study Annals of Surgical Treatment and Research
2022-06 RT-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with breast cancer indicate poor prognosis Breast Cancer Research and Treatment
2022-05 Primary endocrine resistance of ER+ breast cancer with ESR1 mutations interrogated by droplet digital PCR NPJ BREAST CANCER
2022-02 No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trial BMC Cancer
2022-02 Association between TP53 mutation and high 21-gene recurrence score in estrogen receptor-positive/HER2-negative breast cancer NPJ BREAST CANCER
2022-02 Added value of abbreviated breast magnetic resonance imaging for assessing suspicious microcalcification on screening mammography—a prospective study European Radiology
2022-01 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 directly binds and stabilizes Nrf2 in breast cancer FASEB JOURNAL
2021-12 A Randomized Controlled Trial for Doing vs. Omitting Intraoperative Frozen Section Biopsy for Resection Margin Status in Selected Patients Undergoing Breast-Conserving Surgery (OFF-MAP Trial) JOURNAL OF BREAST CANCER
2021-12 The Impact of Post-Mastectomy Radiotherapy on Survival Outcomes in Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy Cancers
2021-12 Analysis of risk factors associated with survival in human epidermal growth factor receptor 2-positive ductal carcinoma in situ using Korean Breast Cancer Society Database ANNALS OF SURGICAL TREATMENT AND RESEARCH
2021-12 Relationship of the standard uptake value of <sup>18</sup>F-FDG-PET-CT with tumor-infiltrating lymphocytes in breast tumors measuring ≥ 1 cm SCIENTIFIC REPORTS
2021-10 Diagnostic Accuracy of Nonmass Enhancement at Breast MRI in Predicting Tumor Involvement of the Nipple: A Prospective Study in a Single Institution RADIOLOGY
2021-10 PD-L1 expression evaluated by 22C3 antibody is a better prognostic marker than SP142/SP263 antibodies in breast cancer patients after resection SCIENTIFIC REPORTS
2021-10 Axillary response according to neoadjuvant single or dual human epidermal growth factor receptor 2 (HER2) blockade in clinically node-positive, HER2-positive breast cancer INTERNATIONAL JOURNAL OF CANCER
2021-09 Comparison of clinicopathological characteristics and prognosis in breast cancer patients with different Breast Imaging Reporting and Data System categories ANNALS OF SURGICAL TREATMENT AND RESEARCH
2021-09 Metastasis Risk Assessment Using BAG2 Expression by Cancer-Associated Fibroblast and Tumor Cells in Patients with Breast Cancer Cancers
2021-09 Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer NPJ BREAST CANCER
2021-08 Application of the 21-Gene Recurrence Score in Patients with Early HR-Positive/HER2-Negative Breast Cancer: Chemotherapy and Survival Rate According to Clinical Risk Cancers
2021-07 Is mastectomy with immediate reconstruction safe for patients undergoing neoadjuvant chemotherapy? A nationwide study from Korean Breast Cancer Society BREAST CANCER
2021-07 Body mass index and absolute lymphocyte count predict disease-free survival in Korean breast cancer patients BRITISH JOURNAL OF CANCER
2021-07 Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES BREAST CANCER RESEARCH AND TREATMENT
2021-07 Five-year changes in ovarian function restoration in premenopausal patients with breast cancer taking tamoxifen after chemotherapy: An ASTRRA study report EUROPEAN JOURNAL OF CANCER
2021-07 Clinical and genomic assessment of PD-L1 SP142 expression in triple-negative breast cancer BREAST CANCER RESEARCH AND TREATMENT
2021-06 Using a tailored digital health intervention for family communication and cascade genetic testing in swiss and korean families with hereditary breast and ovarian cancer: Protocol for the dialogue study JMIR RESEARCH PROTOCOLS
2021-06 Real-World Clinical Outcomes of Biosimilar Trastuzumab (CT-P6) in HER2-Positive Early-Stage and Metastatic Breast Cancer FRONTIERS IN ONCOLOGY
2021-06 Immune-modulating Effect of Korean Red Ginseng by Balancing the Ratio of Peripheral T Lymphocytes in Bile Duct or Pancreatic Cancer Patients With Adjuvant Chemotherapy IN VIVO
2021-05 The association between the expression of nuclear Yes-associated protein 1 (YAP1) and p53 protein expression profile in breast cancer patients PLOS ONE
2021-04 Genomic alterations during the in situ to invasive ductal breast carcinoma transition shaped by the immune system MOLECULAR CANCER RESEARCH
2021-04 Clinical Features of Breast Cancer in South Korean Patients with Germline TP53 Gene Mutations JOURNAL OF BREAST CANCER
2021-04 Clinical Outcomes Following Letrozole Treatment according to Estrogen Receptor Expression in Postmenopausal Women: LETTER Study (KBCSG-006) JOURNAL OF BREAST CANCER
2021-04 Association between skeletal muscle loss and the response to neoadjuvant chemotherapy for breast cancer Cancers
2021-02 High Nuclear Expression of Yes-Associated Protein 1 Correlates With Metastasis in Patients With Breast Cancer FRONTIERS IN ONCOLOGY
2020-12 A nationwide, multicenter retrospective study on the effectiveness and safety of eribulin in Korean breast cancer patients (REMARK) BREAST
2020-12 Comparison of resection margin status after single or double radiopaque marker insertion for tumor localization in breast cancer patients receiving neoadjuvant chemotherapy BREAST CANCER RESEARCH AND TREATMENT
2020-10 Comparison of complications according to incision types in nipple-sparing mastectomy and immediate reconstruction BREAST
2020-10 Validation of Clinical Treatment Score post-5 years (CTS5) risk stratification in premenopausal breast cancer patients and Ki-67 labelling index SCIENTIFIC REPORTS
2020-09 Repeat Sentinel Lymph Node Biopsy for Ipsilateral Breast Tumor Recurrence After Breast Conserving Surgery With Sentinel Lymph Node Biopsy: Pooled Analysis Using Data From a Systematic Review and Two Institutions FRONTIERS IN ONCOLOGY
2020-08 Significance of Non-Mass Enhancement in the Subareolar Region on Preoperative Breast Magnetic Resonance Imaging for Nipple-Sparing Mastectomy CLINICAL BREAST CANCER
2020-08 Local Treatment in Addition to Endocrine Therapy in Hormone Receptor-Positive and HER2-Negative Oligometastatic Breast Cancer Patients: A Retrospective Multicenter Analysis BREAST CARE
2020-08 Prognostic value of neutrophil-to-lymphocyte ratio in human epidermal growth factor receptor 2-negative breast cancer patients who received neoadjuvant chemotherapy SCIENTIFIC REPORTS
2020-07 Radiotherapy-induced high neutrophil-to-lymphocyte ratio is a negative prognostic factor in patients with breast cancer Cancers
2020-06 Omission of axillary lymph node dissection in patients who underwent total mastectomy with 1 or 2 metastatic lymph nodes ANNALS OF SURGICAL TREATMENT AND RESEARCH
2020-04 Associations between absolute neutrophil count and lymphocyte-predominant breast cancer BREAST
2020-02 Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial JOURNAL OF CLINICAL ONCOLOGY
2020-02 Genomic signature of the standardized uptake value in <sup>18</sup>F-fluorodeoxyglucose positron emission tomography in breast cancer Cancers
2020-02 A nomogram constructed using intraoperative ex vivo shear-wave elastography precisely predicts metastasis of sentinel lymph nodes in breast cancer EUROPEAN RADIOLOGY
2019-12 RNF208, an estrogen-inducible E3 ligase, targets soluble Vimentin to suppress metastasis in triple-negative breast cancers NATURE COMMUNICATIONS
2019-12 Redefining Eligibility by Analyzing Canceled Intraoperative Radiotherapy as a Boost for Patients Undergoing Breast-Conserving Treatment ANNALS OF SURGICAL ONCOLOGY
2019-11 Survival benefit of postoperative radiotherapy for ductal carcinoma in situ after breast-conserving surgery: a Korean population-based cohort study BREAST CANCER RESEARCH AND TREATMENT
2019-10 The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry BREAST CANCER RESEARCH AND TREATMENT
2019-09 Measuring Tumor Extent Based on Subtypes Using Magnetic Resonance Imaging: Radiologic-Pathologic Discordance and High Positive Margin Rates in Breast Cancer JOURNAL OF BREAST CANCER
2019-08 Aromatase Inhibitors and Newly Developed Nonalcoholic Fatty Liver Disease in Postmenopausal Patients with Early Breast Cancer: A Propensity Score-Matched Cohort Study ONCOLOGIST
2019-08 High A20 expression negatively impacts survival in patients with breast cancer PLOS ONE
2019-07 Comparison of GenesWell BCT Score With Oncotype DX Recurrence Score for Risk Classification in Asian Women With Hormone Receptor-Positive, HER2-Negative Early Breast Cancer FRONTIERS IN ONCOLOGY
2019-06 Five-year overall survival of interval breast cancers is better than non- interval cancers from Korean breast cancer registry ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
2019-02 Low PR in ER(+)/HER2(-) breast cancer: high rates of TP53 mutation and high SUV ENDOCRINE-RELATED CANCER